EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.

The U.S. Pharmacopeia has created new standards to support the emerging field of advanced cell and gene therapies.

Precipitation-based purification method could replace current Protein A–reliant methods, significantly reducing manufacturing costs of mAbs.

Sustainable bioprocessing boosts cyanobacterial pigment production for advanced biomedical, imaging, and commercial applications.

Multiple microbial communities populate cleanrooms, regardless of grade, and aren’t detected by standard monitoring methods.

The U.S. is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing, and commercial sites.

Scripps Research uses advanced AI computing to speed HIV vaccine development by rapidly analyzing clinical data.

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.

Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

This latest corporate clash has Alkermes working to beat back a challenge from H. Lundbeck for sleep disorder drug developer Avadel Pharmaceuticals.

Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...